Table 2.
Relative distribution of nApoECF labeling in VaD
Case | NFTs | Reactive Astrocyts | Blood Vessels |
---|---|---|---|
1 | +++ | ++ | ++ |
2 | - | +++ | +++ |
3 | +++ | ++ | + |
4 | + | - | ++ |
5 | - | - | +++ |
6 | +++ | ++ | +++ |
7 | +++ | - | + |
(-) Denotes absence of any labeling with nApoECF.